MedPath

Polymyxin B Sulfate and Trimethoprim

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP Sterile Rx Only

Approved
Approval ID

76e1be2e-eb19-48d4-9bfb-88537de839ba

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2023

Manufacturers
FDA

RPK Pharmaceuticals, Inc.

DUNS: 147096275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Polymyxin B Sulfate and Trimethoprim

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53002-8621
Application NumberANDA064211
Product Classification
M
Marketing Category
C73584
G
Generic Name
Polymyxin B Sulfate and Trimethoprim
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 16, 2011
FDA Product Classification

INGREDIENTS (7)

BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRIMETHOPRIM SULFATEActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Polymyxin B Sulfate and Trimethoprim - FDA Drug Approval Details